Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The most common: Nausea, especially in the first few weeks and after dose increases
Injection: Type 2 diabetes Lower the risk of heart attack, stroke, and heart-related death in adults with Type 2 diabetes and heart disease Lower the risk of worsening kidney problems and heart-related death in adults with Type 2 diabetes and chronic kidney disease (CKD) Tablets: Type 2 diabetes Lower the risk of heart attack, stroke, and heart-related death in adults with Type 2 diabetes at high risk for these events How Ozempic (semaglutide) works Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) agonist
Insurance Coverage Considerations Canadian provincial drug coverage for obesity medications remains limited
Mounjaro es un agonista de GLP-1 como Ozempic
